Emory Proton Therapy Center
Emory Proton Therapy Center is Georgia's only proton therapy facility, treating adult and pediatric cancer patients with Varian ProBeam pencil beam scanning technology across five treatment rooms in Midtown Atlanta. It has served over 5,000 patients since 2018, operating in clinical affiliation with Winship Cancer Institute of Emory University.
- Company typePrivate
- Founded2018
- HeadquartersAtlanta, United States
- Headcount251–500
- GTM typeB2C
- OfferingServices
What Emory Proton Therapy Center does
Emory Proton Therapy Center (legal entity: Georgia ProtonCare Center, Inc.) is Georgia's only proton therapy facility and one of only 46 proton centers in the United States. The center opened in December 2018 in Midtown Atlanta at 615 Peachtree St NE, following a seven-year development process and approximately $230 million in construction costs. It operates the Varian ProBeam proton therapy system across five treatment rooms—four equipped with 360-degree rotational gantries and one fixed-beam room—powered by a 90-ton cyclotron that accelerates protons for Intensity Modulated Proton Therapy (IMPT) delivered via pencil beam scanning. Each room integrates MRI and cone-beam CT imaging for millimeter-precision tumor targeting. The center is clinically and operationally integrated with the Winship Cancer Institute of Emory University, Georgia's only NCI-designated Comprehensive Cancer Center, with 14 disease-site specialized radiation oncologists and 18 open clinical trials as of the latest data.
The center treats solid tumors across adult and pediatric cancer types, including brain and spine, breast, prostate, head and neck, thoracic, lymphoma, sarcoma, pelvic, esophageal, and pediatric cancers. As of 2025-2026, it has treated over 5,000 cumulative patients since opening. Patient acquisition occurs primarily through physician referrals from Winship and external specialists, self-referrals, and telehealth consultations for regional, national, and international patients. Revenue is generated through direct patient treatment services on a quote-based, pay-as-you-go model, with pricing dependent on condition, number of treatments, medical history, and insurance coverage; the center is contracted with multiple private insurance plans and Medicare. Effective July 1, 2026, the center transitions to a provider-based facility billing model that separates facility fees from professional fees. Headcount is reported at 251-500 employees, and the facility sits on a 2.39-acre site near eight major Atlanta healthcare systems including Emory University Hospital Midtown, Children's Healthcare of Atlanta, Grady Memorial Hospital, and Piedmont Atlanta Hospital.
The center's owner, Georgia ProtonCare Center, Inc. (a Georgia non-profit corporation), filed for Chapter 11 bankruptcy protection on January 22, 2026, to restructure financial obligations while continuing patient operations without interruption. Emory Healthcare, which has been the exclusive provider of patient care services at the center, is seeking ownership of the center's assets through the Chapter 11 process. The strategic technology partnership with Varian Medical Systems remains active, with Varian engineers on-site daily for system monitoring and maintenance. The center's clinical partnership with Winship Cancer Institute provides access to multidisciplinary cancer care, including medical oncology, radiology, pathology, supportive oncology, dieticians, social workers, nurse navigation, palliative care, pain management, and rehabilitation services.
Emory Proton Therapy Center firmographics
Firmographics- Name
- Emory Proton Therapy Center
- Legal name
- Georgia ProtonCare Center, Inc.
- Website
- https://emoryproton.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Emory Proton Therapy Center is Georgia's only proton therapy facility, treating adult and pediatric cancer patients with Varian ProBeam pencil beam scanning technology across five treatment rooms in Midtown Atlanta. It has served over 5,000 patients since 2018, operating in clinical affiliation with Winship Cancer Institute of Emory University.
- Ownership category
- akta.pro rank
Emory Proton Therapy Center industry classification
Industry- Product category
- Radiation Oncology / Proton Therapy Center
- NAICS
- Diagnostic Imaging Centers (621512)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844)
- akta.pro primary industry
- Radiation Oncology (HLAKAFAC)
- akta.pro secondary industries
- Radiation Therapy Planning & Simulation Imaging (CT Sim/MR Sim) (HLAHABAH), Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology) (HLAFAKAB), Radiation Dose Management & Analytics (HLACALAH), Medical Oncology (HLAKAFAB)
Keywords
Where Emory Proton Therapy Center is headquartered
LocationHeadquarters
- HQ city
- Atlanta
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Emory Proton Therapy Center business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Infrastructure, Personnel, Technology or R&D, Operations, Marketing or Sales
Revenue model
- Patient Treatment Services: The center generates revenue through direct patient treatment services including proton therapy sessions, consultations, simulations, and follow-up care. Revenue is based on condition, number of treatments required, medical history, and insurance provider coverage. The center is transitioning to a provider-based facility model effective July 1, 2026, which will result in separate facility fees and professional fees.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Quote-based treatment pricing based on individual patient circumstances |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels6 records
Emory Proton Therapy Center product offering
Product offeringCore offering
Emory Proton Therapy Center delivers advanced radiation treatment for cancer using pencil beam scanning proton therapy (IMPT) via the Varian ProBeam system across five treatment rooms. The center treats multiple cancer types including brain, spine, breast, prostate, head and neck, thoracic, lymphoma, sarcoma, pediatric, and abdominal cancers. It operates as part of the Winship Cancer Institute of Emory University and provides physician referral pathways, telehealth consultations, and access to 18 active clinical trials.
Product overview
Emory Proton Therapy Center is Georgia's only proton therapy center, offering a single integrated cancer treatment service centered on proton beam radiation therapy. The core offering is pencil beam scanning proton therapy (IMPT) delivered via the Varian ProBeam system across five treatment rooms. Treatment services span multiple cancer types including brain, breast, prostate, pediatric, and thoracic cancers. The center operates as part of Winship Cancer Institute of Emory University, integrating with clinical trials, patient support services, physician referral programs, and a structured six-step care path from consultation through survivorship. Additional services include lodging assistance and telehealth options for referring physicians and patients.
Differentiator
Problem solved
Functional benefit
Products and services
- Proton Therapy Treatment An extremely precise form of radiation treatment using positively charged particles (protons) to deliver radiation that matches the size, shape, and depth of a tumor down to the millimeter. Protons stop at the tumor, reducing exposure to surrounding healthy tissue. Available to adult and pediatric cancer patients with various tumor types.
- Cancer-Specific Proton Therapy Programs Specialized proton therapy treatment organized by indication, covering Brain & Spine, Breast, Esophageal, Head & Neck, Lymphoma, Pediatric, Pelvic, Prostate, Sarcoma, Thoracic, and Abdominal cancers. Each indication has disease-site specialized radiation oncologists from the Winship Cancer Institute.
- Clinical Trials Program Access to cutting-edge clinical trials through the Winship Cancer Institute, including trials for hepatocellular carcinoma, glioblastoma, breast cancer, and non-small cell lung cancer. Winship has completed credentialing for proton therapy in NCI-funded clinical trials, expanding trial availability.
Quantifiable outcome
- Up to 60% less radiation to healthy tissue around the tumor compared to traditional radiation
- +4 more outcomes
Companies that use Emory Proton Therapy Center
Customer profileNamed customers7 records
Segments3 records
Ideal customer profiles3 records
Emory Proton Therapy Center technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
Feature4 records
Emory Proton Therapy Center partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and minor.
- Varian Medical SystemscoreVarian equipped the Emory Proton Therapy Center with the ProBeam proton therapy system. The five-treatment room facility features the Varian ProBeam system with four 360-degree rotational gantry rooms and one fixed beam room. Varian engineers are on-site daily for system monitoring, routine maintenance, and technical support.
- Winship Cancer Institute of Emory UniversitycoreEmory Proton Therapy Center is fully integrated into Winship Cancer Institute's care and research model. Radiation oncologists are disease-site specialists from Winship, Georgia's only NCI-designated Comprehensive Cancer Center. The center provides access to advanced therapies and clinical trials in one setting, with multidisciplinary teams including medical oncology, radiology, pathology, supportive oncology, dieticians, social workers, and rehabilitation specialists.
- Emory HealthcarecoreEmory Healthcare is Georgia's most extensive health system including 11 hospitals, The Emory Clinic, 250+ provider locations, and the Emory Healthcare Network with 2,800+ physicians across 70 subspecialties. Emory Healthcare is the parent organization providing operational infrastructure and physician staffing for the proton center.
- Camp SunshineminorCommunity partner that co-hosts art party events for pediatric patients at the Emory Proton Therapy Center, providing creative outlets for expressing feelings during treatment.
- ARCS Foundation (Atlanta Chapter)minorARCS (Achievement Rewards for College Scientists) Foundation Atlanta Chapter members toured the facility in April 2019 to learn about the proton therapy technology and center operations.
Scale indicators7 records
Recent moves6 records
Expansion highlights6 records
Emory Proton Therapy Center competitors and assessment
Company assessmentBroad incumbents
- Mayo Clinic Proton Beam Therapy Program: Mayo Clinic operates proton beam therapy at its Arizona and Minnesota campuses as part of its broader NCI-designated cancer programs. While Mayo is a far larger multi-specialty health system, its proton offering directly overlaps with Emory's clinical indications and academic positioning.
Direct peers
- Provision CARES Proton Therapy Center: Located in Knoxville, Tennessee, Provision CARES operates a Varian ProBeam proton therapy system with three treatment rooms. Serves Southeast regional referrals and is directly comparable to Emory as a community-rooted proton center competing for similar patient populations.
- Penn Medicine Roberts Proton Therapy Center: The Roberts Proton Therapy Center at the University of Pennsylvania is a major academic proton facility serving the Mid-Atlantic region. Operates a Varian ProBeam system and is integrated with Penn's NCI-designated cancer center, comparable to Emory's Winship integration and clinical trial capabilities.
- Northwestern Medicine Proton Center: Located in Warrenville, Illinois, the Northwestern Medicine Proton Center is an established academic proton therapy facility. Operates four treatment rooms with a Varian ProBeam system and serves Midwest regional referrals, directly comparable in technology and academic integration.
- UF Health Proton Therapy Institute: Located in Jacksonville, Florida, this is one of the leading Southeast proton therapy facilities with extensive pediatric and adult programs. Operates multiple treatment rooms and is affiliated with the University of Florida College of Medicine, comparable to Emory's academic integration and regional draw.
- MD Anderson Proton Therapy Center: One of the largest and most established proton therapy centers in the world, located at MD Anderson Cancer Center in Houston. Operates multiple treatment rooms with pencil beam scanning and serves as a national referral center, directly comparable to Emory in technology and academic integration.
- Massachusetts General Hospital Burr Proton Therapy Center: One of the earliest proton therapy centers in the U.S., affiliated with Harvard Medical School and Massachusetts General Hospital. Provides both passive scattering and pencil beam scanning treatments, serving as a research-driven academic proton program directly comparable to Emory's model.
- Seattle Cancer Care Alliance Proton Therapy: The proton therapy center at Fred Hutchinson Cancer Center / Seattle Cancer Care Alliance provides advanced pencil beam scanning in the Pacific Northwest. Operates as an academic proton program integrated with UW Medicine, comparable in technology stack and clinical trial focus.
Others
- Varian Medical Systems (Siemens Healthineers): Varian is the manufacturer of the ProBeam proton therapy system used at Emory's center and a dominant supplier of radiation oncology equipment globally. As Emory's core technology partner with on-site engineers, Varian is the most directly comparable industry participant though not a direct service competitor.
- IBA (Ion Beam Applications): IBA is the world's leading manufacturer of proton therapy systems, competing directly with Varian. While IBA does not operate treatment centers itself, its technology underpins many competing US proton facilities and its commercial performance is tightly correlated with the proton therapy market that Emory serves.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks7 records
Key highlights7 records
Customer concentration
Emory Proton Therapy Center social profiles
Digital presenceEmory Proton Therapy Center compliance and trust
Trust signalCompliance2 records
Emory Proton Therapy Center financial estimates
Financial estimateRevenue estimate
Valuation estimate
Emory Proton Therapy Center leadership team
Management profileNumber of profiles
Profiles2 records
Emory Proton Therapy Center funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Emory Proton Therapy Center M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Emory Proton Therapy Center
What does Emory Proton Therapy Center do?
Emory Proton Therapy Center delivers advanced radiation treatment for cancer using pencil beam scanning proton therapy (IMPT) via the Varian ProBeam system across five treatment rooms. The center treats multiple cancer types including brain, spine, breast, prostate, head and neck, thoracic, lymphoma, sarcoma, pediatric, and abdominal cancers. It operates as part of the Winship Cancer Institute of Emory University and provides physician referral pathways, telehealth consultations, and access to 18 active clinical trials.
Is Emory Proton Therapy Center a public or private company?
Emory Proton Therapy Center is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Emory Proton Therapy Center founded?
Emory Proton Therapy Center was founded in 2018. It employs 251 to 500 people.
Where is Emory Proton Therapy Center based?
Emory Proton Therapy Center is headquartered in Atlanta, United States, in the North America region.
How does Emory Proton Therapy Center make money?
One revenue line is on record: patient Treatment Services.
Who are Emory Proton Therapy Center's main competitors?
Mayo Clinic Proton Beam Therapy Program is listed as a broad incumbent. Direct peers are Provision CARES Proton Therapy Center, Penn Medicine Roberts Proton Therapy Center, Northwestern Medicine Proton Center, UF Health Proton Therapy Institute, MD Anderson Proton Therapy Center, Massachusetts General Hospital Burr Proton Therapy Center and Seattle Cancer Care Alliance Proton Therapy. Others are Varian Medical Systems (Siemens Healthineers) and IBA (Ion Beam Applications).
Does Emory Proton Therapy Center have an API?
No public API is recorded for Emory Proton Therapy Center.
What industry is Emory Proton Therapy Center in?
Emory Proton Therapy Center's product category is Radiation Oncology / Proton Therapy Center. Its primary akta.pro industry code is HLAKAFAC, Radiation Oncology, with a secondary code of HLAHABAH, Radiation Therapy Planning & Simulation Imaging (CT Sim/MR Sim). Its NAICS code is 621512 and its SIC code is 8011.